A RANDOMIZED CLINICAL-TRIAL OF TITRATED DOSE SUBCUTANEOUS HEPARIN VERSUS COUMADIN IN THE SECONDARY PROPHYLAXIS OF PATIENTS WITH VENOUS THROMBOSIS
Conferences
- Overview
- Research
- Additional Document Info
- View All